FDA.reportPublic FDA data

ActHIB 34 MCG per 0.5 ML Injection

RxCUI
1300468
RxNorm name
ActHIB 34 MCG per 0.5 ML Injection
Display name
ActHIB 34 MCG per 0.5 ML Injection
Full name
ActHIB 34 MCG per 0.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125145PentacelDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine351(a)Rx2026-09-01
103935Acthib,OmnihibHaemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8143d01c-4911-40db-95b2-47f3ebea2a7dActHIB vaccine 0.5 ML Injection [PSN] · 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] [SBD] · 0.5 ML ActHIB 0.068 MG/ML Injection [SY] · ActHIB (purified capsular polysaccharide 10 MCG conjugated to inactivated tetanus toxoid 24 MCG) per 0.5 ML Injection [SY] · ActHIB 34 MCG per 0.5 ML Injection [SY]521These highlights do not include all the information needed to use ActHIB® safely and effectively. See full prescribing information for ActHIB. ActHIB [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular Injection Initial U.S. Approval: 199320260527
67d5c665-ca88-49ba-b7d3-7145d9878cf0ActHIB vaccine 0.5 ML Injection [PSN] · 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] [SBD] · 0.5 ML ActHIB 0.068 MG/ML Injection [SY] · ActHIB (purified capsular polysaccharide 10 MCG conjugated to inactivated tetanus toxoid 24 MCG) per 0.5 ML Injection [SY] · ActHIB 34 MCG per 0.5 ML Injection [SY]513These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine for injectable suspension, for intramuscular use Initial U.S. Approval: 200820260428
e7a819d7-a597-4c91-9078-7cd20ac34410ActHIB vaccine 0.5 ML Injection [PSN] · 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] [SBD] · 0.5 ML ActHIB 0.068 MG/ML Injection [SY] · ActHIB (purified capsular polysaccharide 10 MCG conjugated to inactivated tetanus toxoid 24 MCG) per 0.5 ML Injection [SY] · ActHIB 34 MCG per 0.5 ML Injection [SY]51These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Suspension for Intramuscular Injection Initial U.S. Approval: 200820250516